FDA Inspection
GlaxoSmithKline dba Human Genome Sciences IncGlaxoSmithKline dba Human Genome Sciences Inc – FDA Inspection, Dec 11, 2023
Record Details
This FDA Inspection record concerns GlaxoSmithKline dba Human Genome Sciences Inc, with an inspection on December 11, 2023, issued by the Baltimore District Office.
- Inspection Date
- December 11, 2023
- Person
View Company Profile
ID · bc0ea99b-2d1e-421a-81f4-998e8c743f9b
Inspection Facts
- Inspection number
- 1226290
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of GlaxoSmithKline dba Human Genome Sciences Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| July 31, 2025 | Not classified | Baltimore District Office | |
| March 15, 2019 | Not classified | Baltimore District Office | |
| August 30, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for GlaxoSmithKline dba Human Genome Sciences Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.